U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. (Potassium Iodide) KI in Radiation Emergencies-Questions and Answers
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

(Potassium Iodide) KI in Radiation Emergencies-Questions and Answers December 2002

Download the Final Guidance Document
Final
Docket Number:
None found
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guidance provides answers to questions that FDA has received as state and local governments develop emergency response plans involving the use of potassium iodide (KI) to protect against the effects of radioactive iodine accidentally or intentionally released into the atmosphere. KI is recommended for use as an adjunct to other emergency measures, such as evacuation and control of the food supply to avoid ingestion of contaminated foodstuffs. When used correctly, KI can prevent or reduce the uptake of radioiodine by the thyroid gland. KI provides optimal protection when administered immediately prior to or in conjunction with passage of a radioactive cloud. The incorporation of KI into radiation emergency response plans is at the discretion of state and local governments.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: None found.

Back to Top